Clinical Experience

Clinical Experience

ProtocolLocationClinical PhaseIndicationCompletion Status
MLP-001ChinaPhase IHealthy VolunteersCompleted
WEX-US-001Canada / USPhase IPK study in Healthy Male VolunteersCompleted
WEX-001CanadaPhase IHealthy VolunteersCompleted
WEX-002CanadaPhase IHealthy VolunteersCompleted
WEX-015CanadaPhase IHealthy VolunteersCompleted
MLP-002ChinaPhase IIaCancer Patients
(Refractory pain)
Completed
WEX-003CanadaPhase IIaCancer Patients
(Refractory Pain)
Completed
WEX-008CanadaPhase IIaCancer Patients
(Refractory Pain)
Completed
WEX-014CanadaPhase IIbCancer Patients
(Refractory Pain)
Completed
WEX-014OLCanadaPhase IIbCancer Patients
(Refractory Pain)
Completed
TEC-006Canada/Australia/New ZealandPhase IIICancer Patients
(Refractory Pain)
Completed
TEC-006OLCanada/Australia/New ZealandPhase IIICancer Patients
(Refractory Pain)
Completed
TTX-CINP-201-PKUnited StatesPhase IPK Study in Healthy VolunteersCompleted
TTX-CINP-201United StatesPhase IIChemotherapy-Induced Neuropathic PainCompleted
TTX-TQT-101 United States Phase I Cardiovascular Effect of Tetrodotoxin in Healthy Volunteers Completed